ROS/PI3K/Akt and Wnt/β-catenin signalings activate HIF-1α-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer.
Dong S, Liang S, Cheng Z, Zhang X, Luo L, Li L, Zhang W, Li S, Xu Q, Zhong M, Zhu J, Zhang G, Hu S. · 2022
Read ROS/PI3K/Akt and Wnt/β-catenin signalings activate HIF-1α-induced metabolic reprogramming to impart 5-fluorouracil resistance in colorectal cancer. by Dong S, Liang S, Cheng Z, Zhang X, Luo L, Li L, Zhang W, Li S, Xu Q, Zhong M, Zhu J, Zhang G, Hu S. (2022) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc8742403.txt.
Description
Dong and co-authors show how a hypoxia-linked protein drives drug resistance in colorectal cancer by rewiring glucose use. Resistance to 5-fluorouracil is a standing clinical problem. The team built three resistant cell line models. They measured glucose and lactate use, enzyme levels, and metabolite pools in each.
Resistant cells showed stronger glycolysis and a stronger side pathway. The protein HIF-1α was higher in resistant cells and patient samples. High levels linked to failed chemotherapy and poor survival. Two signal routes switched the protein on without low oxygen. Knocking the protein down, or blocking it with drugs, restored drug sensitivity. The authors name it a marker and target.
Catalog record
| CREATOR | Dong S, Liang S, Cheng Z, Zhang X, Luo L, Li L, Zhang W, Li S, Xu Q, Zhong M, Zhu J, Zhang G, Hu S. |
|---|---|
| YEAR | 2022 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 115 KB |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |